2013
DOI: 10.1038/onc.2013.416
|View full text |Cite
|
Sign up to set email alerts
|

SRChing for the substrates of Src

Abstract: By the mid 1980's, it was clear that the transforming activity of oncogenic Src was linked to the activity of its tyrosine kinase domain and attention turned to identifying substrates, the putative next level of control in the pathway to transformation. Among the first to recognize the potential of phosphotyrosine-specific antibodies, Parsons and colleagues launched a risky shotgun-based approach that led ultimately to the cDNA cloning and functional characterization of many of today's best-known Src substrate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
54
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(55 citation statements)
references
References 181 publications
1
54
0
Order By: Relevance
“…All of these targets are regulated by SRC family kinase activity. 69,70 Western blotting confirmed the observed decrease in total FAK and an increase in ECadherin (data not shown), suggestive of a more epithelial and less invasive state. 71 MCL-1 antagonism also decreased the auto-phosphorylation site Y1148 in EGFR indicating suppression of invasion activity, perhaps due to loss of cSRC activation.…”
Section: Mcl-1 Is a New Regulator Of Protein Kinase Signalling Duringsupporting
confidence: 58%
“…All of these targets are regulated by SRC family kinase activity. 69,70 Western blotting confirmed the observed decrease in total FAK and an increase in ECadherin (data not shown), suggestive of a more epithelial and less invasive state. 71 MCL-1 antagonism also decreased the auto-phosphorylation site Y1148 in EGFR indicating suppression of invasion activity, perhaps due to loss of cSRC activation.…”
Section: Mcl-1 Is a New Regulator Of Protein Kinase Signalling Duringsupporting
confidence: 58%
“…To address this further, we assessed both SRC activation and phosphorylation of paxillin. SRC is recruited to phosphorylated Y397 FAK at focal adhesions where it phosphorylates several proteins including paxillin (Y118) [4446]. FAK also phosphorylates paxillin [47, 48].…”
Section: Resultsmentioning
confidence: 99%
“…It is well known that CD148 dephosphorylates the suppressive tyrosine residue (Y529) in Src tyrosine kinase and increases its activity [19], [41], [42]. Further, Src is known to play a key role in the establishment of E-cadherin cell-cell adhesion [43], [44]. Therefore, we also evaluated the dephosphorylation of Src Y529.…”
Section: Resultsmentioning
confidence: 99%